Home › Funds › Simplify Asset Management Inc. › MIST
Simplify Asset Management Inc. position in MIST
MILESTONE PHARMACEUTICALS IN · Health Care
Simplify Asset Management Inc. reported holding 3,349,379 shares of MIST (MILESTONE PHARMACEUTICALS IN) in its Q3 2026 13F filing — a position valued at US$2.9M, representing 0.05% of its reported portfolio and ranking #48 among its reported holdings. Simplify Asset Management Inc. has disclosed MIST holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Simplify Asset Management Inc.'s MIST position evolved
Simplify Asset Management Inc. first disclosed a stake in MIST in Q1 2025 at 850,000 shares (US$680K). The position peaked in Q3 2025 at 2,832,974 shares, worth US$5.7M. Across 7 filings, Simplify Asset Management Inc. increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 3,349,379 shares valued at US$2.9M. Notable position changes include a 186% increase in Q3 2025 (shares rose 1% over the following quarter), a 47% trim in Q4 2025 (shares fell 41% over the following quarter), a 122% increase in Q2 2026 (shares fell 35% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 850.00K | $680.09K | New |
| Q2 2025 | 990.00K | $1.92M | Add |
| Q3 2025 | 2.83M | $5.67M | Add |
| Q4 2025 | 1.51M | $3.04M | Reduce |
| Q1 2026 | 1.51M | $1.79M | Hold |
| Q2 2026 | 3.35M | $4.49M | Add |
| Q3 2026 | 3.35M | $2.90M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MIST and 13F data
MIST (MILESTONE PHARMACEUTICALS IN) is a Health Care company. 29 other funds we track also report a position in MIST — the largest reported positions include Propel Bio Management, LLC (US$8.2M), Pavaki Capital Management LLC (US$8.1M), Kalehua Capital Management LLC (US$1.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MIST
- Propel Bio Management, LLC 9.45M sh · $8.18M · Q3 2026
- Pavaki Capital Management LLC 9.34M sh · $8.08M · Q3 2026
- Kalehua Capital Management LLC 1.65M sh · $1.43M · Q3 2026
- Lion Point Capital, LP 820.00K sh · $1.10M · Q2 2026
More on Simplify Asset Management Inc.
FAQ
How long has Simplify Asset Management Inc. held MIST?
Simplify Asset Management Inc. has disclosed MIST holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Simplify Asset Management Inc.'s current position in MIST?
As of Q3 2026, Simplify Asset Management Inc. holds 3.35M shares of MIST (MILESTONE PHARMACEUTICALS IN), valued at $2.90M, representing 0.05% of its reported portfolio and ranking #48.
Has Simplify Asset Management Inc. been buying or selling MIST?
In the latest 13F filing (Q3 2026), Simplify Asset Management Inc. held unchanged its position in MIST. The position peaked in Q3 2025 at 2.83M shares.
Which other funds hold MIST?
Other major institutional holders of MIST include Propel Bio Management, LLC, Pavaki Capital Management LLC, Kalehua Capital Management LLC, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.